Verismo Therapeutics Welcomes Dr. Mala Talekar As Vice President of Clinical Development

Jul 11, 2023•over 2 years ago

Position

Vice President of Clinical Development

Company

Verismo Therapeutics

Mala Talekar

PhiladelphiaBiotechnology

Description

Verismo Therapeutics, a clinical-stage CAR-T company, Penn spinout, and pioneer of the novel KIR-CAR platform technology, today announced that Dr. Mala Talekar, MBBS, DABP, DNB has joined the company as Vice President of Clinical Development.

Company Information

Company

Verismo Therapeutics

Location

3675 Market St., Ste. 200

Philadelphia, Pennsylvania, United States

About

About Verismo Therapeutics Verismo Therapeutics is a pioneer in dual-chain KIR-CAR technology, on track to bring its first asset into first-in-human clinical trials in 2023.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Verismo Therapeutics Welcomes Dr. Mala Talekar As Vice President of Clinical Development

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Executive Insights

Company Information